{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T12:28:19Z","timestamp":1792758499915,"version":"4.5.0"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Immunology"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.clim.2021.108749","type":"journal-article","created":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T14:56:44Z","timestamp":1619881004000},"page":"108749","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Detection of anti-mitochondrial 2-oxoacid dehydrogenase complex subunit's antibodies for the diagnosis of Primary Biliary Cholangitis"],"prefix":"10.1016","volume":"268","author":[{"given":"Elisabet","family":"Poyatos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Morandeira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joan","family":"Climent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginia","family":"Mas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9","family":"Castellote","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordi","family":"Bas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.clim.2021.108749_bb0005","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1111\/liv.13686","article-title":"Primary biliary cholangitis in British Columbia first nations: clinical features and discovery of novel genetic susceptibility loci","volume":"38","author":"Asuri","year":"2018","journal-title":"Liver Int."},{"issue":"33","key":"10.1016\/j.clim.2021.108749_bb0010","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.4254\/wjh.v8.i33.1419","article-title":"Recent advances in the diagnosis and treatment of primary biliary cholangitis","volume":"8","author":"Huang","year":"2016","journal-title":"World J. Hepatol."},{"issue":"7","key":"10.1016\/j.clim.2021.108749_bb0015","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1053\/j.gastro.2015.07.061","article-title":"Development and validation of a scoring system to predict outcomes of patients with primary biliary cirrhosis receiving ursodeoxycholic acid therapy","volume":"149","author":"Lammers","year":"2015","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.clim.2021.108749_bb0020","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s40744-017-0074-2","article-title":"Chronic autoimmune epithelitis in Sj\u00f6gren's syndrome and primary biliary cholangitis: a comprehensive review","volume":"4","author":"Selmi","year":"2017","journal-title":"Rheumatol. Ther."},{"key":"10.1016\/j.clim.2021.108749_bb0025","article-title":"Practice guidance from the American Association for the study of liver diseases","volume":"2018","author":"Lindor","year":"2018","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.clim.2021.108749_bb0030","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1002\/hep.28859","article-title":"Large-scale characterization study of patients with antimitochondrial antibodies but nonestablished primary biliary cholangitis","volume":"65","author":"Dahlqvist","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.clim.2021.108749_bb0035","article-title":"The importance of autoantibody detection in primary biliary cirrhosis","volume":"6","author":"Cancado","year":"2015","journal-title":"Front. Immunol."},{"issue":"12","key":"10.1016\/j.clim.2021.108749_bb0040","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1097\/PAS.0b013e318222b579","article-title":"Practical hepatic pathology: a diagnostic aproach","volume":"35","author":"Saxena","year":"2011","journal-title":"Am. J. Surg. Pathol."},{"issue":"10","key":"10.1016\/j.clim.2021.108749_bb0045","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.3748\/wjg.v20.i10.2606","article-title":"Autoantibodies in primary biliary cirrhosis: recent progress in research on the pathogenetic and clinical significance","volume":"20","author":"Yamagiwa","year":"2014","journal-title":"World J. Gastroenterol."},{"issue":"1","key":"10.1016\/j.clim.2021.108749_bb0050","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.jhep.2017.03.022","article-title":"EASL clinical practice guidelines: the diagnosis and management of patients with primary biliary cholangitis","volume":"67","author":"Hirschfield","year":"2017","journal-title":"J. Hepatol."},{"issue":"11","key":"10.1016\/j.clim.2021.108749_bb0055","doi-asserted-by":"crossref","DOI":"10.1515\/cclm-2013-0926","article-title":"The accuracy of the anti-mitochondrial antibody and the M2 subtype test for diagnosis of primary biliary cirrhosis: a meta-analysis","volume":"52","author":"Hu","year":"2014","journal-title":"Clin. Chem. Lab. Med. (CCLM)"},{"key":"10.1016\/j.clim.2021.108749_bb0060","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.cca.2016.11.021","article-title":"Clinical relevance of combined anti-mitochondrial M2 detection assays for primary biliary cirrhosis","volume":"464","author":"Han","year":"2017","journal-title":"Clin. Chim. Acta"},{"issue":"9039","key":"10.1016\/j.clim.2021.108749_bb0065","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1016\/S0140-6736(96)04410-8","article-title":"Natural history of early primary biliary cirrhosis","volume":"348","author":"Metcalf","year":"1996","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.clim.2021.108749_bb0070","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1515\/cclm-2017-1152","article-title":"Reference standards for the detection of anti-mitochondrial and anti-rods\/rings autoantibodies","volume":"56","author":"Calise","year":"2018","journal-title":"Clin. Chem. Lab. Med. (CCLM)"},{"key":"10.1016\/j.clim.2021.108749_bb0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1386-6346(99)00079-0","article-title":"Analysis of two major anti-M2 antibodies (anti-PDC-E2\/ anti-BCOADC-E2) in primary biliary cirrhosis: relationship to titers of immunofluorescent antimitochondrial antibody","volume":"18","author":"Miyakawa","year":"2000","journal-title":"Hepatol. Res."},{"issue":"4","key":"10.1016\/j.clim.2021.108749_bb0080","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/S0168-8278(96)80219-4","article-title":"Antimitochondrial antibody and primary biliary cirrhosis: can there be one without the other?","volume":"25","author":"O'Donohue","year":"1996","journal-title":"J. Hepatol."},{"issue":"2","key":"10.1016\/j.clim.2021.108749_bb0085","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.dld.2004.09.019","article-title":"The Western immunoblotting pattern of anti-mitochondrial antibodies is independent of the clinical expression of primary biliary cirrhosis","volume":"37","author":"Muratori","year":"2005","journal-title":"Dig. Liver Dis."},{"key":"10.1016\/j.clim.2021.108749_bb0090","first-page":"129","article-title":"Serial analysis of antimitochondrial antibody in patients with primary biliary cirrhosis","volume":"11","author":"Benson","year":"2004","journal-title":"Clin. Dev. Immunol."},{"issue":"2","key":"10.1016\/j.clim.2021.108749_bb0095","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1080\/08916930290016556","article-title":"Clinical significance of positive immunoblotting but negative immunofluorescence for antimitochondrial antibodies in patients with liver diseases other than primary biliary cirrhosis","volume":"35","author":"Masuda","year":"2002","journal-title":"Autoimmunity"},{"issue":"8","key":"10.1016\/j.clim.2021.108749_bb0100","doi-asserted-by":"crossref","DOI":"10.1515\/CCLM.2000.107","article-title":"Automated enzymatic mitochondrial antibody assay for the diagnosis of primary biliary cirrhosis","volume":"38","author":"Jensen","year":"2000","journal-title":"Clin. Chem. Lab. Med."},{"issue":"1","key":"10.1016\/j.clim.2021.108749_bb0105","doi-asserted-by":"crossref","DOI":"10.1515\/cclm-2017-0249","article-title":"The diagnostic accuracy of biomarkers for diagnosis of primary biliary cholangitis (PBC) in anti-mitochondrial antibody (AMA)-negative PBC patients: a review of literature","volume":"56","author":"de Liso","year":"2017","journal-title":"Clin. Chem. Lab. Med. (CCLM)"},{"issue":"3","key":"10.1016\/j.clim.2021.108749_bb0110","first-page":"145","article-title":"A practical review of primary biliary cholangitis for the gastroenterologist","volume":"15","author":"Onofrio","year":"2019"},{"issue":"1","key":"10.1016\/j.clim.2021.108749_bb0115","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.patbio.2007.05.001","article-title":"Detection of M2 antimitochondrial antibodies by dot blot assay is more specific than by enzyme linked immunosorbent assay","volume":"56","author":"Bargou","year":"2008","journal-title":"Pathol. Biol."},{"issue":"3","key":"10.1016\/j.clim.2021.108749_bb0120","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1515\/cclm-2019-0655","article-title":"Evaluation of the primary biliary cholangitis-related serologic profile in a large cohort of Belgian systemic sclerosis patients","volume":"58","author":"Florin","year":"2020","journal-title":"Clin. Chem. Lab. Med. (CCLM)"},{"issue":"7","key":"10.1016\/j.clim.2021.108749_bb0130","doi-asserted-by":"crossref","first-page":"471","DOI":"10.3109\/08916934.2013.801461","article-title":"Clinical significance of the fluctuation of primary biliary cirrhosis-related autoantibodies during the course of the disease","volume":"46","author":"Gatselis","year":"2013","journal-title":"Autoimmunity"},{"key":"10.1016\/j.clim.2021.108749_bb0135","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1046\/j.1440-1746.2001.02377.x","article-title":"Changes in titers of antimitochondrial and antinuclear antibodies during the course of primary biliary cirrhosis","volume":"16","author":"Masuda","year":"2001","journal-title":"J. Gastroenterol. Hepatol."},{"issue":"6","key":"10.1016\/j.clim.2021.108749_bb0140","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1007\/BF02065530","article-title":"Autoimmune cholangitis: a variant of primary biliary cirrhosis","volume":"40","author":"Goodman","year":"1995","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.clim.2021.108749_bb0145","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1016\/0016-5085(94)90829-X","article-title":"Autoimmune cholangiopathy: the result of consecutive primary biliary cirrhosis and autoimmune hepatitis?","volume":"107","author":"Colombato","year":"1994","journal-title":"Gastroenterology"},{"key":"10.1016\/j.clim.2021.108749_bb0150","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.jaut.2017.07.003","article-title":"Development of autoantibodies precedes clinical manifestations of autoimmune diseases: a comprehensive review","volume":"83","author":"Ma","year":"2017","journal-title":"J. Autoimmun."},{"issue":"3","key":"10.1016\/j.clim.2021.108749_bb0155","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.jaut.2011.06.005","article-title":"Epitope spreading of the anti-CYP2D6 antibody response in patients with autoimmune hepatitis and in the CYP2D6 mouse model","volume":"37","author":"Hintermann","year":"2011","journal-title":"J. Autoimmun."},{"issue":"3","key":"10.1016\/j.clim.2021.108749_bb0160","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1002\/hep.1840100321","article-title":"Antimitochondrial antibodies in primary biliary cirrhosis recognize both specific peptides and shared epitopes of the M2 family of antigens","volume":"10","author":"Flannery","year":"1989","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.clim.2021.108749_bb0165","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/j.1478-3231.2007.01651.x","article-title":"Antimitochondrial antibody-negative primary biliary cirrhosis: a subset of primary biliary cirrhosis","volume":"28","author":"Liu","year":"2008","journal-title":"Liver Int."},{"issue":"5","key":"10.1016\/j.clim.2021.108749_bb0170","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1373\/clinchem.2008.118299","article-title":"New ELISA for detecting primary biliary cirrhosis\u2013specific antimitochondrial antibodies","volume":"55","author":"D\u00e4hnrich","year":"2009","journal-title":"Clin. Chem."},{"issue":"9","key":"10.1016\/j.clim.2021.108749_bb0705","first-page":"561","article-title":"Diagnosis, Treatment, and Monitoring of Patients With Primary Biliary Cholangitis","volume":"12","author":"Poordad","year":"2016","journal-title":"Gastroenterol. Hepatol. (N Y)"},{"key":"10.1016\/j.clim.2021.108749_bb0710","doi-asserted-by":"crossref","first-page":"182","DOI":"10.5114\/ceji.2016.60993","article-title":"Liver damage in primary biliary cirrhosis and accompanied by primary Sj\u00f6gren\u2019s syndrome: a retrospective pilot study","volume":"2","author":"Zhu","year":"2016","journal-title":"Cent. Eur. J. Immunol."},{"issue":"3","key":"10.1016\/j.clim.2021.108749_bb0715","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/0009-8981(80)90353-8","article-title":"Serum IgM in primary biliary cirrhosis","volume":"108","author":"Taal","year":"1980","journal-title":"Clin. Chim. Acta."},{"issue":"1","key":"10.1016\/j.clim.2021.108749_bb0720","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgast-2017-000158","article-title":"Clinical characteristics of antimitochondrial antibody-positive patients at a safety net health care system in Arizona","volume":"4","author":"Tan","year":"2017","journal-title":"BMJ Open Gastroenterol."}],"container-title":["Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661621000863?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661621000863?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,25]],"date-time":"2024-10-25T15:32:34Z","timestamp":1729870354000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521661621000863"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":37,"alternative-id":["S1521661621000863"],"URL":"https:\/\/doi.org\/10.1016\/j.clim.2021.108749","relation":{},"ISSN":["1521-6616"],"issn-type":[{"value":"1521-6616","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Detection of anti-mitochondrial 2-oxoacid dehydrogenase complex subunit's antibodies for the diagnosis of Primary Biliary Cholangitis","name":"articletitle","label":"Article Title"},{"value":"Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clim.2021.108749","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"108749"}}